Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention
- PMID: 39281573
- PMCID: PMC11401039
- DOI: 10.1016/j.heliyon.2024.e36839
Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention
Abstract
Tumor-associated macrophages play an important role in the tumor immune microenvironment, and regulating the function of tumor-associated macrophages has important therapeutic potential in tumor therapy. Mature macrophages could migrate to the tumor microenvironment, influencing multiple factors such as tumor cell proliferation, invasion, metastasis, extracellular matrix remodeling, immune suppression, and drug resistance. As a major component of the tumor microenvironment, tumor-associated macrophages crosstalk with other immune cells. Currently, tumor-associated macrophages have garnered considerable attention in tumor therapy, broadening the spectrum of drug selection to some extent, thereby aiding in mitigating the prevailing clinical drug resistance dilemma. This article summarizes the recent advances in tumor-associated macrophages concerning immunology, drug targeting mechanisms for tumor-associated macrophages treatment, new developments, and existing challenges, offering insights for future therapeutic approaches. In addition, this paper summarized the impact of tumor-associated macrophages on current clinical therapies, discussed the advantages and disadvantages of targeted tumor-associated macrophages therapy compared with existing tumor therapies, and predicted and discussed the future role of targeted tumor-associated macrophages therapy and the issues that need to be focused on.
Keywords: Immunity; TAMs; Targeted therapy; Tumor.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.Cancer Med. 2023 May;12(10):11049-11072. doi: 10.1002/cam4.5489. Epub 2023 Feb 16. Cancer Med. 2023. PMID: 36794651 Free PMC article. Review.
-
Targeting tumor associated macrophages in hepatocellular carcinoma.Biochem Pharmacol. 2022 May;199:114990. doi: 10.1016/j.bcp.2022.114990. Epub 2022 Mar 11. Biochem Pharmacol. 2022. PMID: 35288152 Review.
-
The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.Front Oncol. 2020 Nov 3;10:590941. doi: 10.3389/fonc.2020.590941. eCollection 2020. Front Oncol. 2020. PMID: 33224886 Free PMC article. Review.
-
The role of tumor-associated macrophage in breast cancer biology.Histol Histopathol. 2018 Feb;33(2):133-145. doi: 10.14670/HH-11-916. Epub 2017 Jul 6. Histol Histopathol. 2018. PMID: 28681373 Review.
-
Targeting tumor-associated macrophages: A potential treatment for solid tumors.J Cell Physiol. 2021 May;236(5):3445-3465. doi: 10.1002/jcp.30139. Epub 2020 Nov 16. J Cell Physiol. 2021. PMID: 33200401 Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials